vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.

CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $35.2M, roughly 1.8× NATIONAL RESEARCH CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 5.1%, a 28.9% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs -0.2%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

CAC vs NRC — Head-to-Head

Bigger by revenue
CAC
CAC
1.8× larger
CAC
$64.3M
$35.2M
NRC
Higher net margin
CAC
CAC
28.9% more per $
CAC
34.0%
5.1%
NRC
Faster 2-yr revenue CAGR
CAC
CAC
Annualised
CAC
22.6%
-0.2%
NRC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CAC
CAC
NRC
NRC
Revenue
$64.3M
$35.2M
Net Profit
$21.9M
$1.8M
Gross Margin
Operating Margin
13.3%
Net Margin
34.0%
5.1%
Revenue YoY
-4.6%
Net Profit YoY
-72.6%
EPS (diluted)
$1.29
$49.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
NRC
NRC
Q1 26
$64.3M
Q4 25
$68.1M
$35.2M
Q3 25
$65.4M
$34.6M
Q2 25
$62.3M
$34.0M
Q1 25
$60.1M
$33.6M
Q4 24
$47.6M
$36.9M
Q3 24
$45.0M
$35.8M
Q2 24
$42.8M
$35.0M
Net Profit
CAC
CAC
NRC
NRC
Q1 26
$21.9M
Q4 25
$22.6M
$1.8M
Q3 25
$21.2M
$4.1M
Q2 25
$14.1M
$-106.0K
Q1 25
$7.3M
$5.8M
Q4 24
$14.7M
$6.6M
Q3 24
$13.1M
$5.7M
Q2 24
$12.0M
$6.2M
Operating Margin
CAC
CAC
NRC
NRC
Q1 26
Q4 25
41.5%
13.3%
Q3 25
40.5%
22.4%
Q2 25
28.5%
4.7%
Q1 25
10.3%
25.6%
Q4 24
38.7%
26.0%
Q3 24
35.2%
22.3%
Q2 24
34.7%
25.3%
Net Margin
CAC
CAC
NRC
NRC
Q1 26
34.0%
Q4 25
33.1%
5.1%
Q3 25
32.4%
11.9%
Q2 25
22.6%
-0.3%
Q1 25
12.2%
17.2%
Q4 24
30.8%
17.8%
Q3 24
29.1%
15.9%
Q2 24
28.0%
17.6%
EPS (diluted)
CAC
CAC
NRC
NRC
Q1 26
$1.29
Q4 25
$1.33
$49.58
Q3 25
$1.25
$0.18
Q2 25
$0.83
$-0.01
Q1 25
$0.43
$0.25
Q4 24
$1.00
$0.27
Q3 24
$0.90
$0.24
Q2 24
$0.81
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
NRC
NRC
Cash + ST InvestmentsLiquidity on hand
$4.1M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$710.0M
$14.0M
Total Assets
$7.0B
$134.9M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
NRC
NRC
Q1 26
Q4 25
$4.1M
Q3 25
$2.2M
Q2 25
$5.3M
Q1 25
$2.5M
Q4 24
$4.2M
Q3 24
$3.5M
Q2 24
$485.0K
Total Debt
CAC
CAC
NRC
NRC
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$48.7M
Q2 24
$33.3M
Stockholders' Equity
CAC
CAC
NRC
NRC
Q1 26
$710.0M
Q4 25
$696.6M
$14.0M
Q3 25
$676.4M
$14.3M
Q2 25
$652.1M
$21.3M
Q1 25
$640.1M
$29.7M
Q4 24
$531.2M
$31.3M
Q3 24
$529.9M
$34.6M
Q2 24
$508.3M
$40.2M
Total Assets
CAC
CAC
NRC
NRC
Q1 26
$7.0B
Q4 25
$7.0B
$134.9M
Q3 25
$7.0B
$135.7M
Q2 25
$6.9B
$141.4M
Q1 25
$7.0B
$135.2M
Q4 24
$5.8B
$132.5M
Q3 24
$5.7B
$131.8M
Q2 24
$5.7B
$119.1M
Debt / Equity
CAC
CAC
NRC
NRC
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.41×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
NRC
NRC
Operating Cash FlowLast quarter
$7.2M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
17.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
NRC
NRC
Q1 26
Q4 25
$63.9M
$7.2M
Q3 25
$36.1M
$13.8M
Q2 25
$6.0M
$-1.1M
Q1 25
$1.0M
$6.6M
Q4 24
$60.9M
$6.4M
Q3 24
$-14.5M
$9.4M
Q2 24
$14.5M
$6.8M
Free Cash Flow
CAC
CAC
NRC
NRC
Q1 26
Q4 25
$58.2M
$6.1M
Q3 25
$35.4M
$10.2M
Q2 25
$4.5M
$-4.1M
Q1 25
$-727.0K
$3.7M
Q4 24
$55.4M
$1.9M
Q3 24
$-16.2M
$7.8M
Q2 24
$13.2M
$1.5M
FCF Margin
CAC
CAC
NRC
NRC
Q1 26
Q4 25
85.5%
17.2%
Q3 25
54.1%
29.4%
Q2 25
7.3%
-12.2%
Q1 25
-1.2%
10.9%
Q4 24
116.4%
5.2%
Q3 24
-36.0%
21.8%
Q2 24
30.8%
4.3%
Capex Intensity
CAC
CAC
NRC
NRC
Q1 26
Q4 25
8.4%
3.2%
Q3 25
1.1%
10.4%
Q2 25
2.4%
8.8%
Q1 25
2.9%
8.9%
Q4 24
11.7%
12.0%
Q3 24
3.8%
4.5%
Q2 24
3.0%
15.0%
Cash Conversion
CAC
CAC
NRC
NRC
Q1 26
Q4 25
2.83×
3.99×
Q3 25
1.70×
3.34×
Q2 25
0.43×
Q1 25
0.14×
1.15×
Q4 24
4.15×
0.97×
Q3 24
-1.11×
1.66×
Q2 24
1.21×
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

NRC
NRC

Segment breakdown not available.

Related Comparisons